Rozga J. Liver support technology: An update. Xenotransplantation Sep 2006;13:380-89
The elusive goal of liver support—quest for the Holy Grail. Clinical Medicine 2006;6:482-87
Cerebral blood flow velocity during high volume plasmapheresis in fulminant hepatic failure. Int J Artif Organs 1994;17:353-61
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004;239(5):660-67; discussion 667-70
Interim results of randomized controlled trial of ELADTM in acute-on-chronic liver disease. Hepatology 2007;46 (Supp l)1:91A
Safety and efficacy of the extracorporeal liver assist device (ELAD®) in patients with acute-on-chronic liver failure. J Hepatol 2010;52 (Supp 1):829A
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46:1853-62
Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AoCLF): The relief study. J Hepatol 2010;52 (Supp 1):1184A
Data from Fulmar study 2009. Personal communication
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006;10:R108
Extracorporeal liver support by fractionated plasma separation and adsorption (Prometheus®) in patients with acute-on-chronic liver failure (Helios Study): A prospective randomized controlled multicentre study. J Hepatol 2010;52 (Supp 1):6A.
